1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Brian Balisi conducted an unannounced complaint visit to investigate the allegations listed above. Upon arrival LPA met with staff and explained the reason for the visit. Administrator Lorenzo Banas arrived shortly after.
At approx 09:40 a.m. LPA conducted physical plant, interviewed staff, conducted medication audit as well as obtained and reviewed copies of pertinent documentation relevant to the investigation.
It was reported that "Resident missed medications due to staff negligence" as it was alleged that Client #1 (C1), was not administered Levothyroxine as prescribed. Interviews conducted and records review revealed On September 6, 2024, C1 was prescribed Levothyroxine 50 MCG tablets, to be taken one tablet by mouth twice daily. A review of the Medication Administration Records (MAR) indicated that Levothyroxine was not listed, which indicated it had not been given to C1 as prescribed. According to the Administrator during an annual review on September 26, 2024, attended by C1, C1's Conservator, Tri-Counties Regional Center, and the Administrator, it was discovered that Levothyroxine was not listed on C1's MAR and had not been administered. |